SynovX Recovery 120 C by Xymogen

SynovX Recovery 120 C

Xymogen

$69.99
(No reviews yet) Write a Review
SKU:
XY-JOINT
UPC:
871149000455
Availability:
Usually Ships in 48 to 72 Hours
Minimum Purchase:
1 unit
Already Registered?
How to Gain Access to Our Store?

SynovX Recovery Joint Support Supplement – Glucosamine, Chondroitin & MSM for Joint Health

SynovX Recovery by Xymogen is a comprehensive joint support supplement designed to help maintain healthy cartilage, connective tissue, and overall joint mobility. This advanced glucosamine chondroitin MSM formula provides targeted nutritional support for individuals seeking to promote joint health, flexibility, and comfort. With clinically recognized ingredients, SynovX Recovery helps support structural integrity within the joints while encouraging long-term cartilage support and connective tissue health.

Key SynovX Recovery Benefits

  • Supports joint health and mobility for everyday movement and activity
  • Promotes cartilage support and healthy connective tissue structure
  • Helps maintain comfortable joint function during exercise or aging
  • Provides key nutrients used in glucosamine chondroitin MSM joint formulas
  • Encourages overall joint flexibility and recovery support

How SynovX Recovery Works

SynovX Recovery combines foundational joint nutrients that work together to nourish cartilage and support connective tissue repair processes while promoting healthy joint movement.

Key ingredients include:

  • Glucosamine Sulfate (750 mg): Supports cartilage formation and helps maintain structural integrity within the joints.
  • Chondroitin Sulfate (600 mg): Encourages hydration and resilience of cartilage, helping joints absorb physical stress.
  • Methylsulfonylmethane (MSM) (475 mg): Provides a bioavailable sulfur source that supports connective tissue strength and healthy joint recovery.

This carefully balanced joint health supplement is formulated to support mobility and flexibility while maintaining a favorable safety profile when used as directed. The ingredients are widely studied for their role in cartilage support, and most individuals tolerate them well when incorporated into a daily wellness routine.

SynovX Recovery Is Formulated For

SynovX Recovery is designed for individuals seeking nutritional support for joint comfort, structural resilience, long-term mobility and may be particularly beneficial for:

  • Active adults and athletes looking for joint recovery support
  • Individuals experiencing normal age-related changes in joint mobility
  • People wanting a comprehensive glucosamine chondroitin MSM formula
  • Those interested in supporting connective tissue health and cartilage structure
  • Adults looking to maintain flexible, comfortable joints as part of an active lifestyle

Supplements support your health but do not replace a balanced diet. Always check with your healthcare practitioner if you have doubts about a new supplement. Or you may book a FREE product consultation with Holistic Health Partners. You may want to look at our other Bone, Joint, and Muscle Support products.

Recommendation: Xymogen suggests taking two capsules twice daily, or as directed by your healthcare professional.

Serving Size: 2 Capsules
Servings Per Container: 60

Amount Per Serving:
Glucosamine Sulfate (as glucosamine sulfate sodium chloride) 750 mg
Chondroitin Sulfate (as chondroitin sulfate sodium) S1 600 mg
Methylsulfonylmethane (MSM) 475 mg

Other Ingredients: Capsule (hypromellose and water), ascorbyl palmitate, medium-chain triglyceride oil, and silica.

Contains: Crustacean shellfish (shrimp and crab).

Does Not Contain: Wheat, gluten, corn, yeast, soy, dairy products, fish, peanuts, tree nuts, egg, ingredients derived from genetically modified organisms (GMOs), artificial colors, artificial sweeteners, or artificial preservatives.

Caution: Consult your healthcare professional prior to use. Individuals taking warfarin or other medication should discuss potential interactions with their healthcare professional. Do not use if tamper seal is damaged.

Storage: Keep closed in a cool, dry place out of reach of children.

These statements have not been evaluated by the FDA. This product is not intended to diagnose, treat, cure, or prevent any disease.

Trademarks:
S1. CSBIOACTIVE™ is a trademark licensed by Bioibérica, S.A.U.

Click here to view New Data Sheet

LEGAL NOTICE: Xymogen's Exclusive Professional Formulas are available through select licensed health care professionals. The Internet Sale and Discounting of XYMOGEN formulas are strictly prohibited. covenanthealthproducts.com makes XYMOGEN formulas available only to patients of our clinic. If you are a patient of covenanthealthproducts.com, you may inquire about XYMOGEN by calling (800) 627-6518

References:

  1. Kahan, A., Uebelhart, D., De Vathaire, F., et al. (2009). Long-term effects of chondroitins 4 and 6 sulfate on knee osteoarthritis: The study on osteoarthritis progression prevention, a two-year, randomized, double-blind, placebo-controlled trial. Arthritis & Rheumatism, 60(2), 524–533. https://doi.org/10.1002/art.24320
  2. Möller, I., Pérez, M., Monfort, J., et al. (2010). Effectiveness of chondroitin sulphate in patients with concomitant knee osteoarthritis and psoriasis: A randomized, double-blind, placebo-controlled study. Osteoarthritis and Cartilage, 18(Suppl 1), S32–S40. https://doi.org/10.1016/j.joca.2010.02.018
  3. Wildi, L. M., Raynauld, J. P., Martel-Pelletier, J., et al. (2011). Chondroitin sulphate reduces both cartilage volume loss and bone marrow lesions in knee osteoarthritis patients starting as early as 6 months after initiation of therapy: A randomized, double-blind, placebo-controlled pilot study using MRI. Annals of the Rheumatic Diseases, 70(6), 982–989. https://doi.org/10.1136/ard.2010.139386
  4. Hochberg, M. C., & Clegg, D. O. (2008). Potential effects of chondroitin sulfate on joint swelling: A GAIT report. Osteoarthritis and Cartilage, 16(Suppl 3), S22–S24. https://doi.org/10.1016/j.joca.2008.06.014
  5. Adebowale, A., Du, J., Liang, Z., et al. (2002). The bioavailability and pharmacokinetics of glucosamine hydrochloride and low molecular weight chondroitin sulfate after single and multiple doses to beagle dogs. Biopharmaceutics & Drug Disposition, 23(6), 217–225. https://doi.org/10.1002/bdd.320
  6. Tat, S. K., Pelletier, J. P., Mineau, F., et al. (2010). Variable effects of 3 different chondroitin sulfate compounds on human osteoarthritic cartilage/chondrocytes: Relevance of purity and production process. The Journal of Rheumatology, 37(3), 656–664. https://doi.org/10.3899/jrheum.090556
  7. Barnhill, J. G., Fye, C. L., Williams, W., et al. (2006). Chondroitin product selection for the glucosamine/chondroitin arthritis intervention trial. Journal of the American Pharmacists Association, 46(1), 14–24. https://doi.org/10.1331/154434506775268822
  8. Glucosamine. (n.d.). Retrieved February 4, 2014, from http://www.naturalstandard.com/databases/herbssupplements/glucosamine.asp
  9. Kelly, G. S. (1998). The role of glucosamine sulfate and chondroitin sulfates in the treatment of degenerative joint disease. Alternative Medicine Review, 3(1), 27–39.
  10. Igarashi, M., Kaga, I., Takamori, Y., et al. (2011). Effects of glucosamine derivatives and uronic acids on the production of glycosaminoglycans by human synovial cells and chondrocytes. International Journal of Molecular Medicine, 27(6), 821–827. https://doi.org/10.3892/ijmm.2011.666
  11. Kapoor, M., Mineau, F., Fahmi, H., et al. (2012). Glucosamine sulfate reduces prostaglandin E2 production in osteoarthritic chondrocytes through inhibition of microsomal PGE synthase-1. The Journal of Rheumatology, 39(3), 635–644. https://doi.org/10.3899/jrheum.110815
  12. Largo, R., Alvarez-Soria, M. A., Díez-Ortego, I., et al. (2003). Glucosamine inhibits IL-1beta-induced NFkappaB activation in human osteoarthritic chondrocytes. Osteoarthritis and Cartilage, 11(4), 290–298. https://doi.org/10.1016/S1063-4584(02)00261-5
  13. Selvan, T., Rajiah, K., Nainar, M. S., et al. (2012). A clinical study on glucosamine sulfate versus combination of glucosamine sulfate and NSAIDs in mild to moderate knee osteoarthritis. The Scientific World Journal, 2012, 902676. https://doi.org/10.1100/2012/902676
  14. Tat, S. K., Pelletier, J. P., Vergés, J., et al. (2007). Chondroitin and glucosamine sulfate in combination decrease the pro-resorptive properties of human osteoarthritis subchondral bone osteoblasts: A basic science study. Arthritis Research & Therapy, 9(6), R117. https://doi.org/10.1186/ar2312
  15. Lippiello, L., Woodward, J., Karpman, R., et al. (2000). In vivo chondroprotection and metabolic synergy of glucosamine and chondroitin sulfate. Clinical Orthopaedics and Related Research, 381, 229–240. https://doi.org/10.1097/00003086-200012000-00030
  16. Clegg, D. O., Reda, D. J., Harris, C. L., et al. (2006). Glucosamine, chondroitin sulfate, and the two in combination for painful knee osteoarthritis. New England Journal of Medicine, 354(8), 795–808. https://doi.org/10.1056/NEJMoa052771
  17. Fransen, M., Agaliotis, M., Nairn, L., et al. (2014). Glucosamine and chondroitin for knee osteoarthritis: A double-blind randomized placebo-controlled clinical trial evaluating single and combination regimens. Annals of the Rheumatic Diseases. Advance online publication. https://doi.org/10.1136/annrheumdis-2013-204808
  18. Methylsulfonylmethane (MSM). (2003). Monograph. Alternative Medicine Review, 8(4), 438–441.
  19. Brien, S., Prescott, P., & Lewith, G. (2011). Meta-analysis of the related nutritional supplements dimethyl sulfoxide and methylsulfonylmethane in the treatment of osteoarthritis of the knee. Evidence-Based Complementary and Alternative Medicine, 2011, 528403. https://doi.org/10.1093/ecam/nen023
  20. Usha, P. R., & Naidu, M. U. (2004). Randomized, double-blind, parallel, placebo-controlled study of oral glucosamine, methylsulfonylmethane and their combination in osteoarthritis. Clinical Drug Investigation, 24(6), 353–363. https://doi.org/10.2165/00044011-200424060-00002
  21. Kalman, D. S., Feldman, S., Scheinberg, A. R., et al. (2012). Influence of methylsulfonylmethane on markers of exercise recovery and performance in healthy men: A pilot study. Journal of the International Society of Sports Nutrition, 9(1), 46. https://doi.org/10.1186/1550-2783-9-46
  22. Barmaki, S., Bohlooli, S., Khoshkhahesh, F., et al. (2012). Effect of methylsulfonylmethane supplementation on exercise-induced muscle damage and total antioxidant capacity. Journal of Sports Medicine and Physical Fitness, 52(2), 170–174.